Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283837070> ?p ?o ?g. }
- W4283837070 endingPage "1609" @default.
- W4283837070 startingPage "1609" @default.
- W4283837070 abstract "We focused on the therapeutic effect of pembrolizumab for metastatic urothelial carcinoma (mUC) and evaluated predictive factors for improving clinical outcomes. We conducted a retrospective multicenter cohort study of patients with mUC who received pembrolizumab. The endpoint was to evaluate the association between clinicopathological features and oncological outcomes. A total of 160 patients were enrolled in this study and were divided into two groups: the responder and the non-responder group, according to the best response. They were followed up for a median period of 10 months. The median overall (OS) and progression-free survival (PFS) in this study were 17 and 4 months, respectively. The responder group did not achieve median OS and it was 10 months in the non-responder group (p < 0.001). Similarly, the responder group did not achieve PFS, and it was 2 months in the non-responder group (p < 0.001). Regarding the neutrophil-to-lymphocyte ratio (NLR) after two courses of administration of pembrolizumab, patients with NLR < 3.24 had significantly better oncological outcomes than those with NLR ≥ 3.24. Multivariate analysis showed a significant association between NLR after two courses of pembrolizumab and OS. Therefore, the absolute value of NLR after two courses of pembrolizumab was a significant predictive factor for oncological outcomes." @default.
- W4283837070 created "2022-07-07" @default.
- W4283837070 creator A5003038014 @default.
- W4283837070 creator A5007787213 @default.
- W4283837070 creator A5020572661 @default.
- W4283837070 creator A5021051056 @default.
- W4283837070 creator A5037426292 @default.
- W4283837070 creator A5038817476 @default.
- W4283837070 creator A5040558189 @default.
- W4283837070 creator A5043789061 @default.
- W4283837070 creator A5044592479 @default.
- W4283837070 creator A5048486027 @default.
- W4283837070 creator A5051919877 @default.
- W4283837070 creator A5055415323 @default.
- W4283837070 creator A5062670032 @default.
- W4283837070 creator A5072116617 @default.
- W4283837070 creator A5077624328 @default.
- W4283837070 creator A5079065450 @default.
- W4283837070 creator A5083530791 @default.
- W4283837070 creator A5087654227 @default.
- W4283837070 date "2022-07-06" @default.
- W4283837070 modified "2023-10-14" @default.
- W4283837070 title "The Impact of Neutrophil-to-Lymphocyte Ratio after Two Courses of Pembrolizumab for Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma" @default.
- W4283837070 cites W2019607817 @default.
- W4283837070 cites W2046702136 @default.
- W4283837070 cites W2071358970 @default.
- W4283837070 cites W2076668534 @default.
- W4283837070 cites W2102297555 @default.
- W4283837070 cites W2117352205 @default.
- W4283837070 cites W2336021222 @default.
- W4283837070 cites W2570159314 @default.
- W4283837070 cites W2588916311 @default.
- W4283837070 cites W2760661635 @default.
- W4283837070 cites W2772599579 @default.
- W4283837070 cites W2783295481 @default.
- W4283837070 cites W2783375881 @default.
- W4283837070 cites W2890138337 @default.
- W4283837070 cites W2943108118 @default.
- W4283837070 cites W2999062563 @default.
- W4283837070 cites W3010223451 @default.
- W4283837070 cites W3025026082 @default.
- W4283837070 cites W3128646645 @default.
- W4283837070 cites W3165120554 @default.
- W4283837070 cites W3166751088 @default.
- W4283837070 cites W3169932276 @default.
- W4283837070 cites W3177447256 @default.
- W4283837070 cites W3208214362 @default.
- W4283837070 cites W3209393335 @default.
- W4283837070 cites W4200026971 @default.
- W4283837070 doi "https://doi.org/10.3390/biomedicines10071609" @default.
- W4283837070 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35884914" @default.
- W4283837070 hasPublicationYear "2022" @default.
- W4283837070 type Work @default.
- W4283837070 citedByCount "6" @default.
- W4283837070 countsByYear W42838370702022 @default.
- W4283837070 countsByYear W42838370702023 @default.
- W4283837070 crossrefType "journal-article" @default.
- W4283837070 hasAuthorship W4283837070A5003038014 @default.
- W4283837070 hasAuthorship W4283837070A5007787213 @default.
- W4283837070 hasAuthorship W4283837070A5020572661 @default.
- W4283837070 hasAuthorship W4283837070A5021051056 @default.
- W4283837070 hasAuthorship W4283837070A5037426292 @default.
- W4283837070 hasAuthorship W4283837070A5038817476 @default.
- W4283837070 hasAuthorship W4283837070A5040558189 @default.
- W4283837070 hasAuthorship W4283837070A5043789061 @default.
- W4283837070 hasAuthorship W4283837070A5044592479 @default.
- W4283837070 hasAuthorship W4283837070A5048486027 @default.
- W4283837070 hasAuthorship W4283837070A5051919877 @default.
- W4283837070 hasAuthorship W4283837070A5055415323 @default.
- W4283837070 hasAuthorship W4283837070A5062670032 @default.
- W4283837070 hasAuthorship W4283837070A5072116617 @default.
- W4283837070 hasAuthorship W4283837070A5077624328 @default.
- W4283837070 hasAuthorship W4283837070A5079065450 @default.
- W4283837070 hasAuthorship W4283837070A5083530791 @default.
- W4283837070 hasAuthorship W4283837070A5087654227 @default.
- W4283837070 hasBestOaLocation W42838370701 @default.
- W4283837070 hasConcept C121608353 @default.
- W4283837070 hasConcept C126322002 @default.
- W4283837070 hasConcept C143998085 @default.
- W4283837070 hasConcept C167135981 @default.
- W4283837070 hasConcept C2777701055 @default.
- W4283837070 hasConcept C2777761686 @default.
- W4283837070 hasConcept C2778963024 @default.
- W4283837070 hasConcept C2780057760 @default.
- W4283837070 hasConcept C38180746 @default.
- W4283837070 hasConcept C71924100 @default.
- W4283837070 hasConcept C90924648 @default.
- W4283837070 hasConceptScore W4283837070C121608353 @default.
- W4283837070 hasConceptScore W4283837070C126322002 @default.
- W4283837070 hasConceptScore W4283837070C143998085 @default.
- W4283837070 hasConceptScore W4283837070C167135981 @default.
- W4283837070 hasConceptScore W4283837070C2777701055 @default.
- W4283837070 hasConceptScore W4283837070C2777761686 @default.
- W4283837070 hasConceptScore W4283837070C2778963024 @default.
- W4283837070 hasConceptScore W4283837070C2780057760 @default.
- W4283837070 hasConceptScore W4283837070C38180746 @default.
- W4283837070 hasConceptScore W4283837070C71924100 @default.
- W4283837070 hasConceptScore W4283837070C90924648 @default.